Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Glenn Whelan"'
Autor:
Tim Harrison, Ian D. Pavord, James D. Chalmers, Glenn Whelan, Malin Fagerås, Annika Rutgersson, Laura Belton, Shahid Siddiqui, Per Gustafson
Publikováno v:
ERJ Open Research, Vol 6, Iss 2 (2020)
Asthma is a chronic inflammatory airway disease. Increase in airway inflammation is hypothesised to contribute to worsening of asthma symptoms and deterioration in lung function, resulting in the use of reliever medication. Short-acting β2-agonists
Externí odkaz:
https://doaj.org/article/20f211cb9ac4460b951a67b66f2a5c1c
Autor:
Malin Fagerås, Ian D. Pavord, Per Gustafson, Glenn Whelan, Shahid Siddiqui, Annika Rutgersson, Tim Harrison, Laura Belton, James D. Chalmers
Publikováno v:
ERJ Open Research, Vol 6, Iss 2 (2020)
ERJ Open Research
article-version (VoR) Version of Record
ERJ Open Research
article-version (VoR) Version of Record
Asthma is a chronic inflammatory airway disease. Increase in airway inflammation is hypothesised to contribute to worsening of asthma symptoms and deterioration in lung function, resulting in the use of reliever medication. Short-acting β2-agonists
Autor:
Glenn Whelan, Eric D. Bateman, Nanshan Zhong, J. Mark FitzGerald, Peter J. Barnes, Helen K. Reddel, Vijay Alagappan, Margareta Puu, Paul M. O'Byrne, Rosa Lamarca
Publikováno v:
Airway pharmacology and treatment.
Introduction: In mild asthma, as-needed budesonide/formoterol (BUD/FORM) reduces exacerbation risk vs as-needed terbutaline, with similar reduction to BUD maintenance + as-needed terbutaline (SYGMA 1; NCT02149199). Aims and Objectives: A post-hoc ana
Autor:
Helen K. Reddel, Glenn Whelan, Mark FitzGerald, Eric D. Bateman, Nanshan Zhong, Margareta Puu, Rosa Lamarca, Vijay Alagappan, Paul M. O'Byrne, Peter J. Barnes
Publikováno v:
Airway pharmacology and treatment.
Introduction: Exacerbations can occur even in mild asthma. The risk of exacerbations can be reduced with as-needed budesonide/formoterol (BUD/FORM) or BUD maintenance+as-needed terbutaline vs as-needed terbutaline alone (SYGMA 1; NCT02149199). Aims a
Autor:
JM FitzGerald, H.K. Reddel, Glenn Whelan, Nanshan Zhong, Paul M. O'Byrne, E.D. Bateman, Rosa Lamarca, Margareta Puu, Peter J. Barnes, Vijay Alagappan
Publikováno v:
D101. CLINICAL AND TRANSLATIONAL STUDIES IN ASTHMA AND COPD.
Autor:
Per Gustafson, Glenn Whelan, Shahid Siddiqui, Laura Belton, Tim Harrison, Annika Rutgersson, Malin Fagerås
Publikováno v:
A32. ASTHMA: CLINICAL STUDIES II.
Autor:
Raj Ashok, Amanda R. Rowe, Juan Sanchez-Ramos, Chuanhai Cao, Cynthia R Cimino, Ren Chen, Xiaoyang Lin, Ross T. Ávila, Glenn Whelan
Publikováno v:
Journal of Alzheimer's Disease. 31:843-855
Human granulocyte colony-stimulating-factor (G-CSF) is widely used for treatment of neutropenia and to mobilize stem/progenitor cells for bone marrow transplantation. In studies of thousands of healthy donor subjects treated with G-CSF to mobilize st
Publikováno v:
Clinical and experimental pharmacologyphysiology. 41(8)
Summary Vessel dilator, a hormone synthesized in the heart, eliminates 71% of human small-cell lung cancers and 67% of human breast cancers growing in mice when given subcutaneously (s.c.) via osmotic pumps. The pharmacokinetics of s.c. administered
Autor:
Glenn Whelan
Publikováno v:
Antibody-Mediated Drug Delivery Systems
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7d377ed6a5bf11b141a53fa7ba4fe528
https://doi.org/10.1002/9781118229019.ch22
https://doi.org/10.1002/9781118229019.ch22
Autor:
Stanley J. Szefler, Glenn Whelan
Publikováno v:
Childhood Asthma ISBN: 9780429118043
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bd380abb0052c76cbdd32bd29ed9c95a
https://doi.org/10.1201/b14123-21
https://doi.org/10.1201/b14123-21